ZYBT
Zhengye Biotechnology Holding
$1.59
+$0.02 (+1.27%)Sep 10, 2026
Key metrics
The numbers that frame ZYBT today
- Market cap
- $75.35M
- P/E (TTM)
- -7.4
- EV / FCF
- 43.7
- Gross margin
- 20.5%
- EV / Sales
- 4.6
- ROIC
- -16.1%
- Div yield
- 0%
- Debt / equity
- 0.3
- 52wk Low
- $0.62
- 52wk High
- $11.45
Growth
Revenue and earnings trend for ZYBT
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ZYBT
Is Zhengye Biotechnology Holding a good buy?
Yes. Zhengye Biotechnology Holding has mixed quality and strong momentum. Taken together, the setup leans positive. We think Zhengye Biotechnology Holding is selling at a high price, which cuts against the buy case.
What is the market capitalization of ZYBT?
Zhengye Biotechnology Holding's market capitalization is $75.35M.
What is the P/E ratio for ZYBT stock?
Zhengye Biotechnology Holding's current P/E ratio is -7.4.
What is the 52-week high for ZYBT stock?
The 52-week high for Zhengye Biotechnology Holding is $11.45. The current close of $1.59 is 86.1% below that high.
What is the 52-week low for ZYBT stock?
The 52-week low for Zhengye Biotechnology Holding is $0.62. The current close of $1.59 is 158.1% above that low.
Does ZYBT stock pay dividends?
Zhengye Biotechnology Holding does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ZYBT?
Zhengye Biotechnology Holding's Debt / Equity ratio is 0.3.